NF2 Gene Neurofibromatosis Type 2 Genetic Test in UAE | 2800 AED | DHA Licensed Laboratory

Executive Summary & Core Metrics

✓ Accuracy Guarantee:

99.9% Diagnostic Sensitivity via ISO‑accredited NGS processing – detecting even low‑frequency NF2 pathogenic variants.

✓ Premium Logistics:

VIP Mobile Phlebotomy & Temperature‑Controlled Cold‑Chain Home Collection (Available daily from 8 AM to 11 PM).

✓ Clinical Guidance:

Telephonic post‑test clinical guidance in result interpretation by DHA‑licensed genetic counsellors.

✓ Insurance:

Direct Billing Verification via WhatsApp +971 54 548 8731 — we confirm coverage before your draw.

Test Overview & Methodology

The NF2 Gene Neurofibromatosis Type 2 Genetic Test is a comprehensive next‑generation sequencing assay that analyzes the entire coding region of the NF2 gene for pathogenic mutations associated with Neurofibromatosis type 2.

Feature	Our Test (NGS)	Traditional Sanger Sequencing
Diagnostic Sensitivity	99.9% (complete gene coverage)	~95% (only targeted exons)
Turnaround Time	3–4 Weeks	6–8 Weeks
Price (AED)	2800	3500
Method	NGS (Illumina® platform)	Capillary Electrophoresis

Physician Insight & Safety Protocols

A Note from Lina Osama Zaki Quteineh (DHA License: 9294403):

"As a Consultant Medical Genetics, I emphasize that a positive NF2 mutation result confirms susceptibility but does not define your clinical destiny. Every genetic finding must be correlated with thorough neurological, dermatological, and audiological evaluation. Your care team will use this molecular data to tailor surveillance and timely interventions, because early detection of vestibular schwannomas or meningiomas dramatically improves outcomes."

Medication Advisory

‼ Medication Warning:

Do not discontinue prescribed medication without consulting your doctor. Beta‑blockers, anticonvulsants, or other agents used for symptom management must be reviewed only by your treating physician in light of genetic results.

Exclusion & Emergency Protocol

Exclusion Criteria: Individuals unable to provide informed consent (as per Federal Decree-Law No. 4 of 2016 on Medical Liability), minors without a legal guardian present, and patients with active febrile illness on collection day.
ER Red Flags: Sudden hearing loss, tinnitus, imbalance, facial weakness, visual disturbances, or severe headache – seek emergency care immediately. These may indicate expanding cranial tumors requiring urgent imaging.

Patient FAQ & Clinical Guidance

1. What does the NF2 gene test detect?

This NGS panel detects germline pathogenic variants (single nucleotide, small indels, and copy number changes) across the entire NF2 coding region, confirming hereditary Neurofibromatosis type 2 predisposition. It identifies mutations responsible for bilateral vestibular schwannomas, meningiomas, and spinal tumors even before symptoms appear, enabling proactive surveillance and family cascade testing.

2. How do I prepare for the test?

Provide a detailed three‑generation family pedigree during the mandatory pre‑genetic counseling session, and avoid heavy physical exertion or alcohol for 24 hours before blood collection. Our nurse will collect 5 mL whole blood (or a single drop on an FTA card) using a temperature-controlled cold-chain kit. A clinical history form is required; genetic counsellors will guide you through consent and pedigree documentation.

3. What do the results mean for my family?

A positive NF2 mutation indicates a hereditary condition with a 50% risk of transmission to offspring. Cascade screening for first-degree relatives is recommended. Our genetic counselling team provides dedicated family risk assessment and testing coordination to ensure all at-risk members receive timely evaluation.

UAE Regulatory & Data Privacy Adherence

Data Protection & Compliance

This laboratory operation and data handling strictly adhere to Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. All genetic data is encrypted, access‑controlled, and never shared without explicit patient consent. Our DHA‑licensed facility ensures full compliance with UAE health information governance standards.

Clinical & Logistical Metadata

Test Name	NF2 Gene Neurofibromatosis Type 2 Genetic Test (NGS)
Price (AED)	2,800
Turnaround Time	3–4 Weeks
Sample Type / Matrix	Whole Blood (5 mL) or FTA Card Dried Blood Spot
Methodology Used	Next‑Generation Sequencing (Illumina®)
ICD-10-CM Code	Q85.02
LOINC Code	21655-2
DHA Facility License & Address	License No. 1143 – DNA Labs UAE, Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE